Business

Watertown Company Acquired by Major Pharmaceutical Firm

By |

The following announcement came from Novo Nordisk:

Novo Nordisk and Forma Therapeutics, Holdings Inc. (Nasdaq: FMTX) today announced that they have entered into a definitive agreement under which Novo Nordisk will acquire Forma Therapeutics for USD 20 per share in cash, which represents a total equity value of USD 1.1bn. Forma Therapeutics is a clinical-stage biopharmaceutical company focused on transforming the lives of patients with sickle cell disease (SCD) and rare blood disorders. The acquisition of Forma Therapeutics, including its lead development candidate, etavopivat, is aligned with Novo Nordisk’s strategy to complement and accelerate its scientific presence and pipeline in haemoglobinopathies, a group of disorders in which there is abnormal production or structure of the haemoglobin protein in the red blood cells. “Novo Nordisk has worked for more than 40 years to develop and deliver transformative medicines to patients around the world with rare and devastating diseases. By adding Forma’s differentiated approach to address unmet needs for patients, we are taking a step forward in enhancing our sickle cell disease pipeline,” said Ludovic Helfgott, executive vice president and head of Rare Disease at Novo Nordisk.

Business

Biotech Companies, Educators Talk About How They Can Collaborate at Life Science Panel

By |

Natalie Nigito PhotographyKatie Sherburne, human resources manager at Forma Therapeutics speaks during the Life Sciences Panel at Hosmer School. Looking on, from right to left, are: Chris Nasveschuk, senior vice president of chemistry at C4 Therapeutics, Mark Bamforth, CEO of Arranta Bio, Watertown Superintendent Dede Galdston, and Watertown K-7 Math and Science Coordinator Elizabeth Kaplan

The life science industry has discovered Watertown, with the city becoming home to a growing number of pharmaceutical, medical and other biotech companies. Recently, representatives from a few of these companies joined Watertown educators at a forum hosted by the Watertown Business Coalition. The event took place at the new Hosmer Elementary School on April 27. The groups spoke about how they collaborate, and opportunities for the future.

Around Town

Hear from Local Life Science Companies, See Watertown’s Newest School at WBC Event

By |

The Watertown Business Coalition will be presenting it second annual Life Sciences Panel and Exhibition. The event will be held at the brand new Hosmer Elementary School. The Watertown Business Coalition provided the following information:

We invite you to join us on Wednesday, April 27, from 5:30-7:45 p.m. for our second annual Life Sciences panel and exhibition. See where the life science companies located in Watertown, or soon to be located in Watertown. Get the opportunity to share more about their business and learn and interact with the local business community and Watertown residents.

Biotech

Watertown Company Developing COVID Therapy, Trying to Inspire Future Scientists

By |

Charlie BreitroseBryan Goodwin, chief biologist at Enanta Pharmaceuticals, and Watertown High School Senior Phil Centola look at a new microscope donated by the biotech company. Watertown-based Enanta Pharmaceuticals has a potential therapy for COVID-19 ready for human testing, and it also hopes to develop some future scientists with a donation to Watertown High School. On Monday morning, representatives from Enanta presented three new microscopes donated by the company to the WHS Science Department. The equipment can be hooked up to a tablet or cellphone to make it easier to see objects under magnification, and images can even be shared with other devices. The school had one of the microscopes, said Lynsey Kraemer, the district’s Science Curriculum Coordinator for Grades 8-12, but the district could not afford more.

100 Forge

9 Story Building at Arsenal Yards Fully Leased, 5 Life Science Tenants Coming 100 Forge

By |

Boylston PropertiesA rendering of what the nine-story 100 Forge building at Arsenal Yards will look like. Developers are creating 165,000 sq. ft. of space for biotech companies. The following announcement was provided by Boylston Properties:

Boylston Properties, a Boston-based developer of mixed-use destinations, today announced that 100 Forge, its 165,595 s.f. life sciences building in the heart of Arsenal Yards in Watertown, is fully leased.

Business

New STEM Education Fund Will Provide Grants to Watertown Teachers, Funded by Local Companies, WCF & Life Science Cares

By |

The following announcement was provided by the Watertown Community Foundation and Life Science Cares Boston:

Life Science Cares Boston is collaborating with the Watertown Community Foundation and four Watertown-based life science companies to launch the Watertown STEM Education Fund, a special effort to fund science, technology, engineering & math programming in the Watertown Public Schools. Four corporate contributors — Arranta Bio, C4 Therapeutics, Forma Therapeutics & Landmark Bio — and Life Science Cares have committed a total of $15,000 in funding for teacher-driven requests for supplemental materials, books, equipment, special events and speakers, student programs and experimental school or district-wide initiatives. The fund builds on the Watertown Community Foundation’s annual school-based educational grants program and will increase total funding for the foundation’s grants this fall. “This exciting new partnership and funding commitment will expand our ability to support Watertown teachers through our annual education grant program. Each year we receive far more grant requests than we can fund, particularly in the area of science and technology. This STEM Fund will truly transform our grant giving capacity and provide teachers and our schools with more resources to support students in the classroom,” said Jan Singer, Watertown Community Foundation Executive Director.

23 Elm St.

Life Science Building in East Watertown Approved by Zoning Board

By |

Elm Street PartnersA rendering of the new life science lab building approved to be built at 23 Elm St. The building to the right is the Residence Inn by Marriott hotel. Months after it first appeared before the Zoning Board of Appeal, a three story life science lab building at 23 Elm Street got approval to be constructed on Wednesday night. The proposal first came before the ZBA in February, at a meeting where board members expressed their concerns about the amount of parking for the then 78,000 sq. ft.

Business

Zoning Board Approves Marijuana Dispensary’s New Home; Questions Parking at Proposed Biotech Building

By |

An illustration of the renovation of the former Monro Muffler at 390 Arsenal St. into the new home of Ethos Cannabis. The Zoning Board of Appeals approved the new location for Watertown’s first marijuana dispensary, and also that meeting a decision on a proposed project on Elm Street was not settled because of questions about whether it has enough parking for the biotech labs it would house. Natural Selections, which operates Ethos Cannabis, needs to find a new home because the current site — 23 Elm St. — has been sold and would be replaced by the biotech building that also came in front of the Zoning Board on March 26.